https://www.labiotech.eu/trends-news/tris-and-pediatrix-extend-partnership-for-adhd-portfol/
0
0
30 words
0
Comments
Tris Pharma announced it has expanded its partnership with Pediatrix receiving exclusive rights to commercialize its ADHD portfolio
You are the first to view
Create an account or login to join the discussion